TrialSignal
Clinical trial intelligence report
Increasing Meaning to Reduce Loneliness in Care Partners of Persons With AD/ADRD
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT05460494-Jul 28, 2026
NCT ID
NCT05460494
Status
COMPLETED
Phase
Completed
Sponsor
Northwell Health
Executive brief
Investment-Ready Snapshot
The RELOAD-C trial, sponsored by Northwell Health, addresses a significant public health issue: loneliness among care partners of individuals with AD/ADRD, a population projected to grow as the incidence of these conditions rises. With over 60% of care partners reporting feelings of loneliness, the intervention aims to provide a scalable, web-based solution that could potentially be integrated into broader care frameworks. The incorporation of MCP into the intervention is innovative and may differentiate it from existing support programs that have shown limited efficacy. The findings could inform future product development and partnerships, particularly in the mental health and elder care sectors, where addressing caregiver well-being is increasingly recognized as critical.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05460494
Indication
Loneliness
Modality
behavioral intervention
Target
Meaning-Centered Psychotherapy (MCP) concepts aimed at increasing meaning and purpose in life to reduce loneliness in care partners of persons with Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD).
Intervention
RELOAD-C
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.